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Bariatric surgery and fractures
Surgeons should consider assessing fracture risk in post-surgical patients
Marco Bueter attending surgeon and head of bariatric program
Department of Surgery, Division of Visceral and Transplantation Surgery, University Hospital Zurich, CH-8091 Zurich, Switzerland
Obesity is escalating at an alarming rate globally and threatens
healthcare systems worldwide. Although bariatric surgery has
emerged as an effective treatment, and numbers of operations
performed worldwide have risen sharply,1 many commentators
still question surgical means to treat obesity. Scepticism has
been fuelled by some evidence of negative long term effects
including increased risks for nephrolithiasis and chronic kidney
disease,2 relapse of type 2 diabetes mellitus,3 4 alcohol
consumption,5 and suicide.6
Bariatric surgery may also have detrimental effects on bone
health, indicated by a reduced bone mineral density
postoperatively.7-10However, whether this translates into a higher
fracture risk is unclear.
The linked study by Rousseau and colleagues (doi:10.1136/bmj.
i3794) aims to fill this gap in knowledge and evidence.11 The
authors did a retrospective, nested case-control study including
patients after bariatric surgery (n=12 767), as well as obese
(n=32 028) and non-obese (n=126 760) controls matched for
sex and age. They used data from physician billing claim
databases from 2006 to 2014 to compare the risk and site of
fractures in bariatric patients and controls, making comparisons
both before and after surgery. The first key finding is that
bariatric surgery patients were more likely to sustain fractures
after surgery than were obese (adjusted relative risk 1.38, 95%
confidence interval 1.23 to 1.55) and non-obese control groups
(1.44, 1.29 to 1.59). Secondly, fracture sites changed after
bariatric surgery to a distribution typically associated with
osteoporosis. Thirdly, fracture risk was significantly associated
only with biliopancreatic diversion, which represents less than
5% of bariatric procedures performed worldwide.1
Rousseau and colleagues contribute to an important research
area, exploring the long term effects of bariatric surgery.
Strengths of their study include a large sample size, a long
duration of follow-up, and their comparison of different bariatric
surgical techniques. However, epidemiological registry data
can have specific flaws and limitations that must be taken into
account when interpreting their findings.
Firstly, the authors do not report any potential differences among
the groups in overall use of drugs (for example, steroids),
vitamin D supplementation, menopausal status, or the cause of
fractures. Secondly, the bariatric surgery group and the obese
control group are hard to compare confidently without
information on body weight or body mass index. Individuals
were included in the obese control group if there was a
diagnostic code for obesity, but the authors do not report the
severity of obesity or reasons for medical treatment among
controls.
Thirdly, different observation periods are compared before and
after the surgery. To overcome this potential confounding, the
authors did a longitudinal comparison within the bariatric group
to investigate specifically the change in fracture risk before and
after surgery. They found that the overall risk of fractures was
elevated after the surgery compared with before the operation,
but the difference did not attain statistical significance (adjusted
relative risk 1.08, 0.97 to 1.21). Thus, postoperative differences
between groups may be simply due to the fact that the bariatric
group already had a higher incidence of fractures preoperatively.
However, the statistical significance of the comparison between
the relative fracture risk of bariatric patients (adjusted relative
risk 1.30, 1.21 to 1.39) before surgery and the risk of the obese
control group (1.18, 1.13 to 1.23) is not reported.
The study by Rousseau and colleagues explores valid questions
and represents an important contribution to the evidence
supporting the long termmanagement of patients after bariatric
surgery. However, limitations in the design prevent any
confident answer to the question “does bariatric surgery increase
the risk of fractures?” Causal relations between a treatment and
an event should ideally be investigated in carefully designed
prospective randomised controlled trials. Epidemiological
registry studies have certainly misled us in the past.12-14
As long as our understanding of bone physiology after bariatric
surgery remains limited, and the clinical consequences of
physiological alterations remain untested by appropriate
prospective studies, we have to continue to follow guidelines
on nutritional supplementation that include the best available
evidence.15 On the basis of the data presented by Rousseau and
colleagues, as a bariatric surgeon I will certainly consider
including assessment of fracture risk in the interdisciplinary
algorithm of post-bariatric care for all my patients in the future.
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